Surface Oncology(SURF)

YCL美国财务税务2020-05-20 22:16

$Surface Oncology(SURF)$ 入驻3刀查看全文

牛唐2020-04-15 08:59

$Surface Oncology(SURF)$ 一周时间50%+的收益，恭喜各位加入的球友。$拼多多(PDD)$ $瑞幸咖啡(LK)$查看全文

lily962019-03-15 03:41

$Surface Oncology(SURF)$ 手里剩了些...有点不舍得卖了这是要去7的节奏咩查看全文

lily962019-03-12 22:30

$Surface Oncology(SURF)$ 出货真心不易查看全文

lily962019-03-08 22:07

$Surface Oncology(SURF)$ 奇怪的走势...查看全文

lily962019-02-26 04:58

$Surface Oncology(SURF)$ @crystalcacn 这个你看看啊，我今天搞了点查看全文

lily962019-02-25 23:43

$Surface Oncology(SURF)$ 再等等...查看全文

kccy02122018-10-09 22:14

$Surface Oncology, Inc(SURF)$ 垃圾股票查看全文

牛唐2018-07-31 16:44

$Surface Oncology(SURF)$ FDA授予治疗多发性骨髓瘤的SRF231孤儿药资格，它是一款靶向CD47的单抗药物,是继$Forty Seven(FTSV)$ 的Hu5F9-G4、$Trillium Therapeutics Inc. (TRIL)$ 的TTI-621之后的第三个靶向CD47的孤儿药查看全文

牛唐2018-07-28 22:05

$Surface Oncology(SURF)$ 继续看好surf，研发管线的四个靶点都是全新的：CD47、CD73、CD39、IL-27查看全文

传葛兰素史克(GSK.US)有意收购Surface Oncology(SURF.US)

智通财经APP获悉，据媒体消息，专攻免疫疗法的Surface Oncology(SURF.US)公司收到了葛兰素史克(GSK.US)的收购意向。 报道称，除葛兰素史克之外，Surface Oncology还在寻找其它任何可能的收购者。 此前，百时美施贵宝(BMY.US)在同意收... 网页链接

其他

$Surface Oncology(SURF)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-23-236303  Act: 34  Size: 12 KB 网页链接

生效批准

$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002629  Act: 33  Size: 1 KB 网页链接

生效批准

$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002628  Act: 33  Size: 1 KB 网页链接

招股信息更正说明

$Surface Oncology(SURF)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-231522  Act: 33  Size: 21 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231530  Act: 33  Size: 23 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231534  Act: 33  Size: 23 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231535  Act: 33  Size: 23 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231539  Act: 33  Size: 23 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231542  Act: 33  Size: 23 KB 网页链接

其他

$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231544  Act: 33  Size: 23 KB 网页链接